[PDF][PDF] The dutch guidelines for treatment with infliximab for Crohn's disease
S Vermeire - Abstracts: July-August, 2006 - njmonline.nl
In the current issue of the Netherlands Journal of Medicine, inflammatory bowel disease
(IBD) specialists from the Dutch University Medical Centres publish their guidelines for the
use of infliximab in patients with Crohn's disease. 1 Infliximab is a monoclonal antibody to
tumour necrosis factor-alpha (TNF-a) and is the first biological therapy registered and
approved for the treatment of this chronic inflammatory gastrointestinal disorder. In these
guidelines, the authors give a detailed and very practical overview of all aspects related to …
(IBD) specialists from the Dutch University Medical Centres publish their guidelines for the
use of infliximab in patients with Crohn's disease. 1 Infliximab is a monoclonal antibody to
tumour necrosis factor-alpha (TNF-a) and is the first biological therapy registered and
approved for the treatment of this chronic inflammatory gastrointestinal disorder. In these
guidelines, the authors give a detailed and very practical overview of all aspects related to …
以上显示的是最相近的搜索结果。 查看全部搜索结果